ECSP034653A - GIRASA INHIBITORS AND USES OF THE SAME - Google Patents
GIRASA INHIBITORS AND USES OF THE SAMEInfo
- Publication number
- ECSP034653A ECSP034653A EC2003004653A ECSP034653A ECSP034653A EC SP034653 A ECSP034653 A EC SP034653A EC 2003004653 A EC2003004653 A EC 2003004653A EC SP034653 A ECSP034653 A EC SP034653A EC SP034653 A ECSP034653 A EC SP034653A
- Authority
- EC
- Ecuador
- Prior art keywords
- inhibitors
- relates
- girasa
- same
- compounds
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiere a compuestos de la formula I o un derivado farmacéuticamente aceptable o prodroga del mismo. Los compuestos son útiles como inhibidores de actividad de girasas bacterianas. La presente invención también se refiere a métodos de tratamiento de infecciones bacterianas en mamíferos. La presente invención también se refiere a métodos por decrecimiento de cantidad bacteriana en una muestra biológica.This invention relates to compounds of the formula I or a pharmaceutically acceptable derivative or prodrug thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention also relates to methods of treating bacterial infections in mammals. The present invention also relates to methods by decreasing bacterial amount in a biological sample.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25609400P | 2000-12-15 | 2000-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034653A true ECSP034653A (en) | 2003-07-25 |
Family
ID=33449456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004653A ECSP034653A (en) | 2000-12-15 | 2003-06-12 | GIRASA INHIBITORS AND USES OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| EC (1) | ECSP034653A (en) |
| ZA (1) | ZA200303933B (en) |
-
2001
- 2001-12-12 ZA ZA200303933A patent/ZA200303933B/en unknown
-
2003
- 2003-06-12 EC EC2003004653A patent/ECSP034653A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200303933B (en) | 2004-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0116216A (en) | Gyrase inhibitors and their uses | |
| BRPI0416692A (en) | heterocyclic mek inhibitors and methods of using these | |
| PL374191A1 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections | |
| MXPA05008126A (en) | Gyrase inhibitors and uses thereof. | |
| UY29458A1 (en) | REPLACED HETEROCICLES AND USES OF THE SAME | |
| ECSP003699A (en) | FAB I INHIBITORS | |
| ATE433980T1 (en) | GYRASINE INHIBITORS AND THEIR USES | |
| TR200201505T2 (en) | Pirazolopyrimidines as therapeutic agents | |
| ECSP055640A (en) | PIRAZOL COMPOSITIONS USEFUL AS INHIBITORS OF GSK-3 | |
| ATE370139T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA INHIBITORS FOR THE TREATMENT OF CANCER | |
| NO20055421L (en) | Quinoline derivatives as phosphodiesterase inhibitors | |
| BRPI0409367A (en) | piperidine derivatives renin inhibitors | |
| CY1107747T1 (en) | Substituted tetraacyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| PA8478501A1 (en) | HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS | |
| DE602004020070D1 (en) | THIENOPYRIMIDINE DERIVATIVES AS KALIUM CHANNEL INHIBITORS | |
| EP1171428A4 (en) | FAB I INHIBITORS | |
| PA8678901A1 (en) | DERIVATIVES OF QUINOLINE AS ANTIBACTERIAL AGENTS | |
| BRPI0509660A (en) | beta-carboline compounds useful in treating inflammatory diseases | |
| AR064152A1 (en) | ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD. | |
| ATE419242T1 (en) | PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS | |
| ATE335739T1 (en) | CAK INHIBITORS AND THEIR USES | |
| SE0004101D0 (en) | New use | |
| BRPI0519267A2 (en) | quinoline derivative, its use, production and medicine containing the same | |
| ATE246174T1 (en) | TOSYLPROLINE DERIVATIVES AS THYMIDYLATE SYNTHASE INHIBITORS | |
| UY29012A1 (en) | "OXAZOLIDIDONS AND RELATED COMPOSITIONS AND METHODS" |